CR Bard Inc., BCR is in the exchange NYSE and its industry is Medical Instruments & Supplies in the sector of Healthcare. Based in USA, CR Bard Inc., BCR has a market cap of 16029.76. Since its IPO date on the 4/6/1983, CR Bard Inc., BCR performance year to date is 12.85%. Today CR Bard Inc., BCR has gained -1.07%, with a current price of 213.02.
Ownership of the company is 0.20% for insider ownership while institutional ownership is 90.60%. The management of the company have seen the company have a payout ratio of 22.00%. Return of assets are at 6.30%, with return on investment at 6.40%.
In terms of debt levels and profit levels, CR Bard Inc., BCR is seeing a long-term debt/equity of 1.01. While Total debt/equity is 1.01. With a profit margin of 9.10%, this is combined with a gross margin of 62.50%, and operating margin of 14.10%. CR Bard Inc. ability to meet debt levels, with a current ratio of 2.4, while the quick ratio is 1.9.
For the last year CR Bard Inc., BCR has seen a EPS growth of -52.90%. A performance for the year of 11.84%. The 52-week high is -10.93%, and the 52-week low is 24.14%. The average volume for CR Bard Inc., BCR is 613000.
With a target price of 243.83, can CR Bard Inc., BCR reach this target? Looking at the value indicators of CR Bard Inc., BCR. CR Bard Inc. has a P/E of 42.07 and a forward P/E of 18.85. Perhaps the more useful indicator than P/E, is PEG which has a value of 3.87. CR Bard Inc. also has a P/S and a P/B of 4.53 and 9.68 respectively. For P/cash, CR Bard Inc. has a value of 20.09, while it is 55.18 for P/free cash flow.
At the current price of 213.02, CR Bard Inc. has a dividend yield of 0.49%. We see a return on equity of 21.40%.
Looking more long-term CR Bard Inc., is projected to get an EPS growth for the next five years of 10.87%. In the short-term an EPS growth of 11.14% in the next year is forecasted. This is after a EPS growth of -52.90% for this year and for the last five years a -19.80% growth has been seen.